Abstract

BackgroundAccurately predicting which patients with chronic heart failure (CHF) are particularly vulnerable for adverse outcomes is of crucial importance to support clinical decision making. The goal of the current study was to examine the predictive value on long term heart failure (HF) hospitalisation and all-cause mortality in CHF patients, by exploring and exploiting machine learning (ML) and traditional statistical techniques on a Dutch health insurance claims database.MethodsOur study population consisted of 25,776 patients with a CHF diagnosis code between 2012 and 2014 and one year and three years follow-up HF hospitalisation (1446 and 3220 patients respectively) and all-cause mortality (2434 and 7882 patients respectively) were measured from 2015 to 2018. The area under the receiver operating characteristic (ROC) curve (AUC) was calculated after modelling the data using Logistic Regression, Random Forest, Elastic Net regression and Neural Networks.ResultsAUC rates ranged from 0.710 to 0.732 for 1-year HF hospitalisation, 0.705–0.733 for 3-years HF hospitalisation, 0.765–0.787 for 1-year mortality and 0.764–0.791 for 3-years mortality. Elastic Net performed best for all endpoints. Differences between techniques were small and only statistically significant between Elastic Net and Logistic Regression compared with Random Forest for 3-years HF hospitalisation.ConclusionIn this study based on a health insurance claims database we found clear predictive value for predicting long-term HF hospitalisation and mortality of CHF patients by using ML techniques compared to traditional statistics.

Highlights

  • Predicting which patients with chronic heart failure (CHF) are vulnerable for adverse outcomes is of crucial importance to support clinical decision making

  • Patients had to have a CHF-related claim according to the national diagnosis-treatment classification system called ‘Diagnose Behandeling Combinatie’ (DBC), which is based on a combination of the International Classification of Diseases, 10th revision (ICD-10) and applied treatment [18]

  • Baseline characteristics Our study population consists of 25,776 CHF patients (median age 74 years (Interquartile Range [Interquartile range (IQR)] 66–80 years) and 43.7% women) including 1446 patients with HF hospitalisation in 2015 and 3220 in 2015–2017 and all-cause mortality 2434 and 7882, respectively

Read more

Summary

Introduction

Predicting which patients with chronic heart failure (CHF) are vulnerable for adverse outcomes is of crucial importance to support clinical decision making. Patients had to have a CHF-related claim according to the national diagnosis-treatment classification system called ‘Diagnose Behandeling Combinatie’ (DBC), which is based on a combination of the International Classification of Diseases, 10th revision (ICD-10) and applied treatment [18]. They had to have used at least one medication within the cardiovascular system (“C”) based on the World Health Organization Anatomical Therapeutic Chemical Classification index and Defined Daily Dose (WHO ATC/DDD) in the same period [19]. A total of 25,776 patients were included in the final analysis (Fig. 1)

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call